Transcutaneous immunization, a topical Vaccine application, combines the ad
vantages of needle-free delivery while targeting the immunologically rich m
ilieu of the skin. In animal studies, this simple technique induces robust
systemic and mucosal antibodies against vaccine antigens. Here, we demonstr
ate safe application of a patch containing heat-labile enterotoxin (LT, der
ived from Escherichia coli) to humans, resulting in robust LT-antibody resp
onses. These findings indicate that TCL is feasible for human immunization,
and suggest that TCL may enhance efficacy as well as improve vaccine deliv
ery.